Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2011 Mar;127(3):741–749. doi: 10.1016/j.jaci.2010.12.010

Figure 2. Effect of budesonide on asthma-related outcomes, by overweight status.

Figure 2

Lines represent the difference between treatment arms (budesonide – placebo/nedocromil; negative numbers indicate an improvement in the budesonide arm compared to the non-budesonide arm). Overweight/obese group in orange/circles; non-overweight in green/triangles. A: Average number of prednisone courses per patient since the previous visit. B: Percentage of children reporting any urgent care visits or hospital admissions. Note: Solid lines/symbols represent visits where difference was significant; non-significant time points in dotted lines.